Clinical Trials
- Lymphoma
test
- Lymphoma
test
- Lymphoma, Leukemia
Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release
- Lymphoma
test
- Ages18 years - 70 years
- GenderBoth
- Phase 1 Cancers
test